Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Rhonda Bitting, M.D.

TitleAssistant Professor
InstitutionWake Forest School of Medicine
DepartmentInternal Medicine - Hematology and Oncology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Praharaj PP, Bhutia SK, Nagrath S, Bitting RL, Deep G. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine. Biochim Biophys Acta Rev Cancer. 2018 Apr; 1869(2):117-127. PMID: 29360544.
      View in: PubMed
    2. Jackson G, Fino N, Bitting RL. Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland. Clin Med Insights Oncol. 2017; 11:1179554917743981. PMID: 29242703.
      View in: PubMed
    3. Logue JM, Kiani B, Bitting RL. Pazopanib and Statin-Induced Rhabdomyolysis. Case Rep Oncol. 2017 Sep-Dec; 10(3):954-957. PMID: 29279698.
      View in: PubMed
    4. Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, Pagni M, Liu L, Nykter M, Chen K, Hawkins GA, Grant SC, Petty WJ, Alistar AT, Levine EA, Staren ED, Langefeld CD, Miller V, Singal G, Petro RM, Robinson M, Blackstock W, Powell BL, Wagner LI, Foley KL, Abraham E, Pasche B, Zhang W. Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center. Theranostics. 2017; 7(11):2914-2923. PMID: 28824725.
      View in: PubMed
    5. Armstrong AJ, Halabi S, Healy P, Alumkal JJ, Winters C, Kephart J, Bitting RL, Hobbs C, Soleau CF, Beer TM, Slottke R, Mundy K, Yu EY, George DJ. Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer. Eur J Cancer. 2017 08; 81:228-236. PMID: 28502694.
      View in: PubMed
    6. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang W. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. J Hematol Oncol. 2017 05 04; 10(1):100. PMID: 28472989.
      View in: PubMed
    7. Gupta S, Li J, Kemeny G, Bitting RL, Beaver J, Somarelli JA, Ware KE, Gregory S, Armstrong AJ. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2017 Mar 01; 23(5):1346-1357. PMID: 27601596.
      View in: PubMed
    8. Davis K, Wood S, Dill E, Fesko Y, Bitting RL, Harrison MR, Armstrong AJ, Moul JW, George DJ. Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution. Clin J Oncol Nurs. 2015 Jun; 19(3):297-303. PMID: 26000580.
      View in: PubMed
    9. Bitting RL, Healy P, Halabi S, George DJ, Goodin M, Armstrong AJ. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer. Urol Oncol. 2015 Mar; 33(3):110.e1-9. PMID: 25595577.
      View in: PubMed
    10. Bitting RL, Schaeffer D, Somarelli JA, Garcia-Blanco MA, Armstrong AJ. The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev. 2014 Sep; 33(2-3):441-68. PMID: 24414193.
      View in: PubMed
    11. Bitting RL, Healy P, Creel PA, Turnbull J, Morris K, Wood SY, Hurwitz HI, Starr MD, Nixon AB, Armstrong AJ, George DJ. A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma. Clin Genitourin Cancer. 2014 Aug; 12(4):241-50. PMID: 24685058.
      View in: PubMed
    12. Bitting RL, Boominathan R, Rao C, Kemeny G, Foulk B, Garcia-Blanco MA, Connelly M, Armstrong AJ. Development of a method to isolate circulating tumor cells using mesenchymal-based capture. Methods. 2013 Dec 01; 64(2):129-36. PMID: 23845299.
      View in: PubMed
    13. Armstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, Embree E, Morris K, Winters C, Jaffe T, Fleming M, George DJ. A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer. Clin Genitourin Cancer. 2013 Dec; 11(4):397-406. PMID: 23830964.
      View in: PubMed
    14. Bitting RL, Armstrong AJ. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer. 2013 Jun; 20(3):R83-99. PMID: 23456430.
      View in: PubMed
    15. Bitting RL, Armstrong AJ. Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancer. Cancer J. 2013 Jan-Feb; 19(1):25-33. PMID: 23337754.
      View in: PubMed
    16. Bitting RL, Armstrong AJ. Prognostic, predictive, and surrogate factors for individualizing treatment for men with castration-resistant prostate cancer. Am Soc Clin Oncol Educ Book. 2012; 292-7. PMID: 24451752.
      View in: PubMed
    17. Bitting RL, Armstrong AJ, George DJ. Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T? Clin Med Insights Oncol. 2011; 5:325-32. PMID: 22084621.
      View in: PubMed
    18. Bitting RL, Madden J, Armstrong AJ. Therapy for non-clear cell histologies in renal cancer. Curr Clin Pharmacol. 2011 Aug; 6(3):169-80. PMID: 21861801.
      View in: PubMed
    19. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 2011 Aug; 9(8):997-1007. PMID: 21665936.
      View in: PubMed
    20. Bitting RL, Bent S, Li Y, Kohlwes J. The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis. Blood Coagul Fibrinolysis. 2009 Oct; 20(7):517-23. PMID: 19644360.
      View in: PubMed
    21. Powers JS, Choi L, Bitting R, Gupta N, Buchowski M. Rapid measurement of total body water to facilitate clinical decision making in hospitalized elderly patients. J Gerontol A Biol Sci Med Sci. 2009 Jun; 64(6):664-9. PMID: 19228780.
      View in: PubMed
    22. Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma. 2007 Sep; 48(9):1728-35. PMID: 17786708.
      View in: PubMed
    23. Dhar S, Bitting RL, Rylova SN, Jansen PJ, Lockhart E, Koeberl DD, Amalfitano A, Boustany RM. Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons. Ann Neurol. 2002 Apr; 51(4):448-66. PMID: 11921051.
      View in: PubMed
    Bitting's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _